IV vitamin C doubled survival from 8 to 16 months in 34 pancreatic cancer patients
Louis shares a University of Iowa piece on a phase 2 trial of IV ascorbate added to chemotherapy for stage 4 pancreatic cancer, published in Redox Biology in November 2024.



